BACKGROUND AND OBJECTIVES: The use of self-report questionnaires to detect characteristics of altered central pain processing, as seen in centralized pain disorders such as fibromyalgia, allow for the epidemiological studies of pain patients. Here, we assessed the relationship between reporting high levels of pain while taking opioids and the presence of characteristics associated with centralized pain. METHODS: We evaluated 582 patients taking opioid medications using validated measures of clinical pain, neuropathic pain symptoms, mood, and functioning. A multivariate linear regression model was used to assess the association between levels of pain while taking opioids and presenting with characteristics consistent with having centralized pain. RESULTS: We found that 49% of patients taking opioids continued to report severe pain (≥ 7/10). In multivariate analysis, factors associated with having higher levels of pain in opioid users included higher fibromyalgia survey scores (P = 0.001), more neuropathic pain symptoms (P < 0.001), and higher levels of depression (P = 0.002). Although only 3.2% were given a primary diagnosis of fibromyalgia by their physician, 40.8% met American College of Rheumatology survey criteria for fibromyalgia. CONCLUSIONS: Our findings suggest that patients with persistently high pain scores despite opioid therapy are more likely than those with lower levels of pain to present with characteristics associated with having centralized pain. This study cannot determine whether these characteristics were present before (fibromyalgia-like patient) or after the initiation of opioids (opioid-induced hyperalgesia). Regardless, patients with a centralized pain phenotype are thought to be less responsive to opioids and may merit alternative approaches.
BACKGROUND AND OBJECTIVES: The use of self-report questionnaires to detect characteristics of altered central pain processing, as seen in centralized pain disorders such as fibromyalgia, allow for the epidemiological studies of painpatients. Here, we assessed the relationship between reporting high levels of pain while taking opioids and the presence of characteristics associated with centralized pain. METHODS: We evaluated 582 patients taking opioid medications using validated measures of clinical pain, neuropathic pain symptoms, mood, and functioning. A multivariate linear regression model was used to assess the association between levels of pain while taking opioids and presenting with characteristics consistent with having centralized pain. RESULTS: We found that 49% of patients taking opioids continued to report severe pain (≥ 7/10). In multivariate analysis, factors associated with having higher levels of pain in opioid users included higher fibromyalgia survey scores (P = 0.001), more neuropathic pain symptoms (P < 0.001), and higher levels of depression (P = 0.002). Although only 3.2% were given a primary diagnosis of fibromyalgia by their physician, 40.8% met American College of Rheumatology survey criteria for fibromyalgia. CONCLUSIONS: Our findings suggest that patients with persistently high pain scores despite opioid therapy are more likely than those with lower levels of pain to present with characteristics associated with having centralized pain. This study cannot determine whether these characteristics were present before (fibromyalgia-like patient) or after the initiation of opioids (opioid-induced hyperalgesia). Regardless, patients with a centralized pain phenotype are thought to be less responsive to opioids and may merit alternative approaches.
Authors: Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield Journal: J Rheumatol Date: 2011-02-01 Impact factor: 4.666
Authors: Laxmaiah Manchikanti; Salahadin Abdi; Sairam Atluri; Carl C Balog; Ramsin M Benyamin; Mark V Boswell; Keith R Brown; Brian M Bruel; David A Bryce; Patricia A Burks; Allen W Burton; Aaron K Calodney; David L Caraway; Kimberly A Cash; Paul J Christo; Kim S Damron; Sukdeb Datta; Timothy R Deer; Sudhir Diwan; Ike Eriator; Frank J E Falco; Bert Fellows; Stephanie Geffert; Christopher G Gharibo; Scott E Glaser; Jay S Grider; Haroon Hameed; Mariam Hameed; Hans Hansen; Michael E Harned; Salim M Hayek; Standiford Helm; Joshua A Hirsch; Jeffrey W Janata; Alan D Kaye; Adam M Kaye; David S Kloth; Dhanalakshmi Koyyalagunta; Marion Lee; Yogesh Malla; Kavita N Manchikanti; Carla D McManus; Vidyasagar Pampati; Allan T Parr; Ramarao Pasupuleti; Vikram B Patel; Nalini Sehgal; Sanford M Silverman; Vijay Singh; Howard S Smith; Lee T Snook; Daneshvari R Solanki; Deborah H Tracy; Ricardo Vallejo; Bradley W Wargo Journal: Pain Physician Date: 2012-07 Impact factor: 4.965
Authors: Jennifer F Waljee; David C Cron; Rena M Steiger; Lin Zhong; Michael J Englesbe; Chad M Brummett Journal: Ann Surg Date: 2017-04 Impact factor: 12.969
Authors: Lisa A Uebelacker; Risa B Weisberg; Debra S Herman; Genie L Bailey; Megan M Pinkston-Camp; Michael D Stein Journal: Pain Med Date: 2015-06-27 Impact factor: 3.750
Authors: Ronald A Wasserman; Afton L Hassett; Steven E Harte; Jenna Goesling; Herbert L Malinoff; Daniel W Berland; Jennifer Zollars; Stephanie E Moser; Chad M Brummett Journal: Reg Anesth Pain Med Date: 2015 Nov-Dec Impact factor: 6.288
Authors: Ronald A Wasserman; Afton L Hassett; Steven E Harte; Jenna Goesling; Herbert L Malinoff; Daniel W Berland; Jennifer Zollars; Stephanie E Moser; Chad M Brummett Journal: J Nat Sci Date: 2017-02
Authors: Jennifer Cheng; Richard L Kahn; Jacques T YaDeau; Alexander Tsodikov; Enrique A Goytizolo; Carrie R Guheen; Stephen C Haskins; Joseph A Oxendine; Answorth A Allen; Lawrence V Gulotta; David M Dines; Chad M Brummett Journal: Clin J Pain Date: 2016-08 Impact factor: 3.442
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Francis E Lotrich; Susan Zickmund; Eva Szigethy; Andrea F DiMartini Journal: Clin Gastroenterol Hepatol Date: 2014-11-05 Impact factor: 11.382
Authors: Paul E Hilliard; Jennifer Waljee; Stephanie Moser; Lynn Metz; Michael Mathis; Jenna Goesling; David Cron; Daniel J Clauw; Michael Englesbe; Goncalo Abecasis; Chad M Brummett Journal: JAMA Surg Date: 2018-10-01 Impact factor: 14.766
Authors: Joanne Salas; Jeffrey F Scherrer; Frank David Schneider; Mark D Sullivan; Kathleen K Bucholz; Thomas Burroughs; Laurel A Copeland; Brian K Ahmedani; Patrick J Lustman Journal: Pain Date: 2017-02 Impact factor: 7.926
Authors: Chad M Brummett; Rishi R Bakshi; Jenna Goesling; Daniel Leung; Stephanie E Moser; Jennifer W Zollars; David A Williams; Daniel J Clauw; Afton L Hassett Journal: Pain Date: 2016-06 Impact factor: 7.926